Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Metabolon Announces Quantose IR Test Launched in Mexico

Published: Friday, June 06, 2014
Last Updated: Friday, June 06, 2014
Bookmark and Share
Quantose IR™ test available through PATIA Biopharma to help prevent type 2 diabetes.

Metabolon has announced that its Quantose IR™ prediabetes test is now available to physicians in Mexico through PATIA Biopharma, its commercial partner there.

In addition, PATIA and its affiliates will be using Quantose IR in two large-scale studies to test up to three million adults and teenagers in Mexico who are overweight or obese and/or have a family history of diabetes.

It is estimated that one out of every five adults in Mexico has prediabetes, a condition that often progresses to type 2 diabetes if left untreated. Early detection is crucial, because prediabetes can be reversed with lifestyle changes and treatment.

With Quantose IR, PATIA has a new tool to aid doctors and patients in making informed and timely decisions that could potentially delay or prevent the onset of type 2 diabetes, a serious public health issue affecting more than 10 percent of the adult population in Mexico.

In fact, an average of eight people die in that country every hour from complications related to the disease, according to the IDF Diabetes Atlas.

Quantose IR is a convenient, cost-effective test that requires only a single fasting blood sample. The test measures the blood concentration levels of specific metabolites, making it possible to detect insulin resistance, an early indication of prediabetes.

In February 2014, Metabolon and PATIA have announced a strategic alliance agreement naming PATIA the exclusive commercial partner for Quantose IR in Mexico. All testing will be performed at the Clínica Ruiz laboratories, which are certified by the American National Accreditation Board (ANAB).

“We’re proud that Quantose IR is now commercially available in Mexico through a dynamic collaboration with PATIA Biopharma,” stated John Ryals, Ph.D., President and CEO at Metabolon. “Treatment of type 2 diabetes is an enormous and rising cost worldwide, and awareness of prediabetes is the first step to avoiding progression. There is no cure for type 2 diabetes, so prevention offers tremendous potential to begin reversing the course of this growing epidemic.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Metabolon and BCM Show Metabolomics May Play Key Role in Precision Medicine
Metabolon’s technology enhances understanding of genetic data and improves health assessment in newly published study.
Wednesday, August 19, 2015
Darin Leigh Joins Metabolon as Chief Commercial Officer
New role to lead commercial strategy for biomarker discovery, precision medicine, and diagnostics products and services.
Tuesday, July 07, 2015
Newly Published Results Support Clinical Validity of Quantose IGT™ Diabetes Test
Results from study were recently published in the Journal of Diabetes Science and Technology.
Saturday, January 24, 2015
DHMRI and Metabolon Announce Strategic Partnership
Agreement to provide expanded metabolomics capabilities.
Wednesday, September 04, 2013
IMDEA Food and Metabolon Announce Strategic Collaboration
Collaboration program to advance nutrition-based personalized medicine.
Wednesday, July 10, 2013
Scientific News
New ACE-inhibiting Molecule Found in the Asparagus
Scientists have determined that sulfur-containing compounds in plants can inhibit ACE.
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Shedding Light On Century-Old Biochemical Mystery
Yale scientists have used magnetic resonance measurements to show how glucose is metabolized in yeast to answer the puzzle of the “Warburg Effect.”
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Metabolon and BCM Show Metabolomics May Play Key Role in Precision Medicine
Metabolon’s technology enhances understanding of genetic data and improves health assessment in newly published study.
Newly Discovered Cells Restore Liver Damage in Mice Without Cancer Risk
The liver is unique among organs in its ability to regenerate after being damaged. Exactly how it repairs itself remained a mystery until recently, when researchers supported by the NIH discovered a type of cell in mice essential to the process
Study Finds Cutting Dietary Fat Reduces Body Fat More than Cutting Carbs
In a recent study, restricting dietary fat led to body fat loss at a rate 68 percent higher than cutting the same number of carbohydrate calories when adults with obesity ate strictly controlled diets.
Inappropriate Medical Food Use in Managing Patients with a Type of Metabolic Disorder
Researchers have proposed that there is a need for more rigorous clinical study of dietary management practices for patients with IEMs, including any associated long-term side effects, which may in turn result in the need to reformulate some medical foods.
Medical Researchers a Step Closer to Developing Anti-Obesity Pill
A weight loss pill could soon be possible thanks to the work of Deakin University medical researchers.
Engineered Bacterium Produces Important Industrial Chemical
A Korean research team has reported the production of 1,3-diaminopropane via fermentation of an engineered bacterium.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!